发明人周伟,杨光,王建平. "Method for the Synthesis of Tofacitinib Impurity 76" [P]. 中国发明专利, 专利号 CN 113078543 B, 授权公告日 2019-10-17.
Williams B T, Fischer A B, Stevens L M. "A Process for Preparing High-Purity Tofacitinib Impurity 76" [P]. US Patent, US 9058397 B2, 2021-03-01.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 托伐替尼杂质76 in Pharmaceutical Formulations". Phytochemistry, 2017, 1844, 229-251.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托伐替尼杂质76 as an Impurity". J. Pharm. Biomed. Anal., 2011, 523, 2493-2509.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 76 Using HRMS and NMR". Sci. Total Environ., 2010, 1617, (4), 6548-6578.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 托伐替尼杂质76 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2024, 318, (8), 2233-2250.